Stock AVTE AEROVATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Aerovate Therapeutics, Inc.

Equities

AVTE

US0080641071

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
17.45 USD -1.19% Intraday chart for Aerovate Therapeutics, Inc. +2.11% -22.89%
May. 13 Aerovate Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 12 Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Aerovate Therapeutics : June 2024 Corporate Presentation
PU
Aerovate Therapeutics : May 2024 Corporate Presentation
PU
Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
AQ
Aerovate Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
AQ
Aerovate Therapeutics : May 2024 Corporate Presentation
PU
Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing
MT
Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing
MT
Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
AQ
Aerovate Therapeutics Q4 Loss Widens
MT
Aerovate Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Aerovate Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
AQ
Aerovate Therapeutics Insider Sold Shares Worth $908,046, According to a Recent SEC Filing
MT
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
AQ
Aerovate Therapeutics, Inc. Announces Board Changes
CI
Aerovate Therapeutics : March 2024 Corporate Presentation
PU
Aerovate Therapeutics Insider Sold Shares Worth $165,628, According to a Recent SEC Filing
MT
Aerovate Therapeutics : December 2023 Corporate Presentation
PU
Aerovate Therapeutics Insider Sold Shares Worth $203,237, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVTE Stock
  4. News Aerovate Therapeutics, Inc.